FDA.reportPublic FDA data

Application 209720

Type
ANDA
Sponsor
AMNEAL PHARMS CO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ERYTHROMYCINERYTHROMYCINTABLET;ORAL250MGNoNo
002ERYTHROMYCINERYTHROMYCINTABLET;ORAL500MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
69238-1484ErythromycinErythromycinAmneal Pharmaceuticals NY LLCANDACurrent
69238-1484ErythromycinErythromycinAmneal Pharmaceuticals NY LLCANDACurrent
69238-1484ErythromycinErythromycinAmneal Pharmaceuticals LLCANDACurrent
69238-1484ErythromycinErythromycinAmneal Pharmaceuticals NY LLCANDACurrent
69238-1484ErythromycinErythromycinAmneal Pharmaceuticals NY LLCANDACurrent
69238-1485ErythromycinErythromycinAmneal Pharmaceuticals NY LLCANDACurrent
69238-1485ErythromycinErythromycinAmneal Pharmaceuticals NY LLCANDACurrent
69238-1485ErythromycinErythromycinAmneal Pharmaceuticals LLCANDACurrent
69238-1485ErythromycinErythromycinAmneal Pharmaceuticals NY LLCANDACurrent
69238-1485ErythromycinErythromycinAmneal Pharmaceuticals NY LLCANDACurrent